The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.
 
Nicholas James
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Janssen Oncology; Merck; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi
 
Joseph van de Wiel
Research Funding - AstraZeneca (Inst)
 
Ana Hughes
Research Funding - AstraZeneca
 
Anne-Marie Hodgkins
No Relationships to Disclose
 
Shaista Hafeez
No Relationships to Disclose
 
Anjali Zarkar
Research Funding - AstraZeneca (Inst)
 
Maria De Santis
Honoraria - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Bayer; BioClin Therapeutics; Bristol-Myers Squibb; Exelixis/Ipsen; Ferring; Gilead Sciences; Immunomedics; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novartis; Orion; Pfizer; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Thermosome
Consulting or Advisory Role - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Eisai; Ferring; Gilead Sciences; GlaxoSmithKline; Immunomedics/Gilead; Ipsen; Janssen; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Novartis; Orion Health; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Takeda; Thermosome
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Ipsen; Janssen; Merck Serono; Pfizer; Roche; Roche/Genentech; Sanofi
 
Omar Din
Research Funding - AstraZeneca (Inst)
 
Romaana Mir
No Relationships to Disclose
 
James Iddenden
No Relationships to Disclose
 
Catalina Vassallo - Bonner
No Relationships to Disclose
 
Sarah Pirrie
No Relationships to Disclose
 
Sophia Magwaro
Research Funding - Astra Zeneca funded the RadIO trial
 
Syed Hussain
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche